VM
VNDA icon

VHCP Management’s Vanda Pharmaceuticals VNDA Stock Holding History

VHCP Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-719,075
Closed -$8.92M – 17
2013
Q4 		$8.92M Buy
719,075
+228,000
+46% +$2.29M 4.8% 9
2013
Q3 		$5.38M Sell
491,075
-296,384
-38% -$3.17M 2.97% 11
2013
Q2 		$6.36M Buy
+787,459
New +$5.3M 4.73% 8

Other funds holding VNDA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

VHCP Management's VNDA Position: Q1 2014 in Review

VHCP Management sold out of Vanda Pharmaceuticals (VNDA) in Q1 2014, closing a stake of 719,075 shares — an estimated $8.92M sold.

VHCP Management first reported a position in VNDA in Q2 2013 and held it in 3 quarters. The position peaked at $8.92M in Q4 2013. 109 funds tracked by Wall St. Rank hold VNDA as of Q1 2014.

  • VHCP Management reported no remaining Vanda Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • VHCP Management sold 719,075 Vanda Pharmaceuticals shares in Q1 2014, an estimated $8.92M.
  • VHCP Management first reported a position in Vanda Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • VHCP Management's Vanda Pharmaceuticals position peaked at $8.92M in Q4 2013.
  • 109 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2014.

Based on VHCP Management's 13F filing for Q1 2014, filed 14 May 2014.